Active Pharmaceutical Ingredient CDMO Market Witnesses Strong Demand for Custom API Manufacturing Services
The global active pharmaceutical ingredient CDMO market size was valued at USD 124.72 billion in 2025. The market is projected to grow at a CAGR of 7.60% from 2026 to 2034. Growth is being fueled by rising demand for outsourced pharmaceutical manufacturing, increasing biologics and specialty drug production, and the need for scalable, high-quality API supply chains. North America and Asia...
0 Commentarii 0 Distribuiri 8 Views 0 previzualizare